A total of 111 clinical isolates of Campylobacter jejuni and 10 clinical isolates of Campylobacter coli were characterized by their susceptibility to nine antimicrobial agents and by their plasmid profiles on agarose gel electrophoresis. All of the C. jejuni isolates were susceptible to chloramphenicol, ciprofloxacin, erythromycin, kanamycin, and nalidixic acid, but 55% were tetracycline resistant. In the 10 C. coli isolates, a high prevalence of multiple-antibiotic resistance was noted. Plasmids were found in 82% of the tetracycline-resistant and 15% of the tetracycline-susceptible C. jejuni isolates. Tetracycline resistance in six randomly selected C. jejuni isolates, which contained 50-or 135-kilobase (kb) plasmids, was transferred by conjugation to a Campylobacter fetus subsp. fetus recipient with recovery of a 50-or a 45-kb plasmid from transconjugants. From one multiple-antibiotic-resistant C. coli isolate, resistance to tetracycline, kanamycin, and chloramphenicol was transferred concomitantly with a 58-kb plasmid, pNR9589. Nonconjugative 98-kb plasmids, pNR9131 and pNR9581, from C. coli isolates with resistance to tetracycline, kanamycin, and erythromycin were shown by cloning experiments to code for at least kanamycin resistance. Restriction digests revealed that 50-kb plasmids from tetracycline-resistant C. jejuni isolates were identical, although plasmids from multiple-antibioticresistant C. coli isolates shared partial DNA homology to each other. Cloning of the kanamycin and chloramphenicol resistance genes of pNR9589 into Escherichia coli showed that the two genes are closely linked or clustered. Double-digestion analysis of the fragments encoding the kanamycin resistance of pNR9131, pNR9581, and pNR9589 showed that these three plasmids contain a common fragment related to kanamycin resistance.
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Campylobacterjejuni is recognized as one of the common causes of acute bacterial enteritis throughout the world (2, 17) . More than 200 strains of C. jejuni and a small number of C. coli strains, 60% of which are from children, are isolated every year in Tokyo Metropolitan Toshima General Hospital.
Taylor et al. (19, 20) and Tenover et al. (21) demonstrated that tetracycline resistance in C. jejuni is mediated by conjugative R plasmids with a size of 60 kilobases (kb), and more recently, Tenover et al. (22) showed that all tetracycline-resistant C. jejuni harbored R plasmids. Most recently, Taylor (18) mapped the tetracycline resistance plasmid. Studies on plasmid detection in Campylobacter spp . have not yet been carried out in Japan, although clinical and epidemiological studies on Campylobacter spp. have been performed extensively. In the present study, we examined the MICs of nine antimicrobial agents against Campylobacter isolates, the plasmid carriage in these isolates, and the relationship between antimicrobial resistance and plasmid carriage in C. jejuni and C. coli. Moreover, we analyzed three plasmids isolated from multiple-antibiotic-resistant C. coli strains by restriction endonuclease digestion and characterization of the cloned resistance genes.
MATERIALS AND METHODS
Bacterial strains. We used 111 C. jejuni and 10 C. coli strains isolated from stools of diarrheal patients at Tokyo * Corresponding author. Identification of isolates. All isolates were tested for the following characteristics: Gram stain, production of oxidase, catalase, and H2S (TSI medium [Eiken Chemicals, Tokyo, Japan] and lead acetate paper strip), growth in the presence of 1% glycine and 3.5% NaCl, growth at 25 and 42°C, and hippurate hydrolysis by the method of Harvey (9) .
Antimicrobial agents and chemicals. The following antimicrobial agents were tested: chloramphenicol (Sankyo Co. Ltd., Tokyo, Japan), tetracycline (Lederle Japan Ltd., Tokyo, Japan), kanamycin (Meiji Seika Kaisha Ltd., Tokyo, Japan), ampicillin (Meiji Seika Kaisha Ltd.), nalidixic acid (Daiichi Seiyaku Co., Ltd., Tokyo, Japan), erythromycin (Dainippon Pharmaceutical Co., Ltd., Osaka, Japan), cephalothin (Shionogi Co., Ltd., Osaka, Japan), metronidazole (Shionogi Co.), and ciprofloxacin (kindly provided by Bayer Yakuhin, Ltd., Tokyo, Japan). Every stock solution of these substances was prepared as specified by the manufacturers. Restriction endonucleases (PstI, BglII, HindIII, HaeIII, and HpaII) and T4 DNA ligase were purchased from Boehringer Mannheim Biochemicals, Tokyo, Japan.
Antimicrobial susceptibility testing. Antimicrobial susceptibility testing was done by the standard agar dilution method established by the Japan Society of Chemotherapy (8) Conjugation experiments. For conjugation, six strains of tetracycline-resistant C. jejuni and three strains of multipleantibiotic-resistant C. coli were used as donors and C. fetus subsp. fetus C-607 was used as a recipient. Broth and plate matings were carried out by the method of Taylor (19) , with the following modification. After the bacterial cells had been cultured in flasks containing heart infusion broth (Difco), equal amounts of donor and recipient cells were mixed at 37°C for 48 h. Transconjugants were selected on plates containing 50 ,ug of nalidixic acid and 25 ,ug of tetracycline per ml at 25°C for 48 h. For plate matings, each donor and recipient was cultured on horse blood-agar plates at 37°C for 48 h. After being scraped from the plates and suspended in saline, both the donor and the recipient were mixed together, spread over blood-agar plates containing antimicrobial agents as described above, and incubated a-t 37°C for 48 h. Some transconjugants were tested again for donor ability by plate mating with a tetracycline-susceptible and plasmid-free C. jejuni strain as recipient. Tetracycline (25 ,ug/ml) and cephalothin (50 ,ug/ml), along with a 42°C growth temperature, were used for counter-selection.
DNA manipulation. Reactions for all endonucleases and T4 DNA ligase were carried out under the conditions specified by the supplier. Agarose gel electrophoresis was performed with a 0.6 to 1.0% agarose gel as described previously (4).
Cloning of resistance genes. Kanamycin and chloramphenicol resistance genes of pNR9131, pNR9581, and pNR9589
were cloned into E. coli X1776 (14) with pUC13 as a vector (15, 27) . Transformants were selected under anaerobic conditions on Penassay agar plates (Difco) containing 25 ,ug of kanamycin or chloramphenicol per ml at 37°C. RESULTS Identification of isolates. All the isolates tested had the characteristics of Campylobacter spp. When the strains were positive for hippurate hydrolysis, they were considered to be C. jejuni; when they were hippurate negative, they were considered to be C. coli.
MICs. The MIC range and the MICs for 50 and 90%o of strains tested (MIC50 and MIC90) for the 111 clinical isolates of C. jejuni and 10 isolates of C. coli are shown in Table 1 . All C. jejuni isolates were susceptible to chloramphenicol (MIC, <25 pugIml), kanamycin (MIC, <25 ,ug/ml), nalidixic acid (MIC, <32 ,ug/ml), erythromycin (MIC, <8 ,ug/ml), and ciprofloxacin (MIC, <12.5 ,ug/ml). Ciprofloxacin was the most active antimicrobial agent tested (MIC50, 0.2 ,ug/ml; MIC90, 0.78 ,ug/ml). Only one isolate (0.9%) was resistant to ampicillin (MIC, .32 ptg/ml). For susceptibility to tetracycline, strains were divided into two groups: either very susceptible or highly resistant. Sixty-one isolates (55%) were resistant to tetracycline (MIC, 2 12.5 ,ug/ml). Metronidazole (MIC50, 50 pug/ml; MIC90, >100 ,ug/ml) and cephalothin (MIC, >100 ,xg/ml) showed poor activity.
Of the C. coli isolates, one was resistant to chloramphenicol, six were resistant to tetracycline, five were resistant to kanamycin, one was resistant to nalidixic acid, and four were resistant to erythromycin. The antimicrobial resistance patterns of C. coli were considerably different from those of C. jejuni in that they showed high-level multiple-antibiotic resistance (Table 2) . Plasmid detection. The results of plasmid detection in 108 isolates of C. jejuni and 10 isolates of C. coli were as follows: 56 C. jejuni (52%) and 7 C. coli (70%) isolates harbored plasmids. Although seven isolates of C. jejuni and one of C. coli had two plasmids, the majority had a single plasmid. The sizes of the plasmids detected ranged from 5.5 to 140 kb. The typical plasmid patterns of the isolates on agarose gel electrophoresis are shown in Fig. 1 . The plasmid sizes were 50 kb in C-142, 135 kb in C-147, 50 and 48 kb in C-150 and C-216, 88 kb in C-166, 98 kb in C-131 and C-5816, and 58 and 5.5 kb in C-589.
Correlation between tetracycline resistance and plasmid carriage. Plasmid distributions among C. jejuni isolates with and without tetracycline resistance were examined. A total of 49 (82%) of 60 tetracycline-resistant isolates carried plasmids, the majority of which ranged from 44 to 64 kb in size. About 50% of the plasmids were 50 kb. Further analysis revealed that 49 (89%) of 55 strains for which the tetracycline MIC was 25 ,ug/ml and higher carried tetracycline resistance plasmids, whereas only one of five strains for which the MIC was 12.5 ,ug/ml had the plasmid. On the other hand, 41 (85%) of 48 tetracycline-susceptible isolates had no plasmid. The antimicrobial resistance and plasmids of C. coli isolates are summarized in Table 2 . For the 10 isolates of C. coli, all of the tetracycline-resistant isolates had plasmids ranging from 5.5 to 98 kb and 3 of the tetracycline-susceptible isolates had no plasmid.
Conjugation experiments. We examined four tetracyclineresistant C. coli isolates and six randomly selected tetracycline-resistant C. jejuni isolates for their ability to transfer tetracycline resistance by conjugation (Table 3 ). Five C. jejuni isolates containing 50-kb plasmids (pNR9122, pNR9124, pNR9142, pNR91S0, and pNR9216) transferred tetracycline resistance to the recipient by conjugation, yielding transconjugants containing the respective plasmids. Strain C-147, containing a 135-kb plasmid, also transferred tetracycline resistance by plate mating, and a 45-kb plasmid was recovered. This unusual finding was obtained twice with 10 colonies examined each time. We could not purify plasmid DNA from C-147 because of its large size. Three plasmids, pNR9166, pNR9131, and pNR9581, from C. coli isolates resistant to tetracycline, kanamycin, and erythromycin were not transferable. From C. coli C-589, which was resistant to chloramphenicol, erythromycin, kanamycin, and tetracycline and contained plasmids pNR9589 (58 kb) and pNR9588 (5.5 kb), resistances to chloramphenicol, kanamycin, and tetracycline but not erythromycin were transferred together with recovery of a 58-kb plasmid. The frequencies of c9njugal transfer in broth mating ranged from 1 x 10-5 to 2.5 x 10-6 transconjugants per donor cell. However, pNR9124 and pNR9147 were not transferable in broth matings and also appeared less transferable than the others in plate matings. Restriction patterns of original and transconjugant plasmids from C. jejuni isolates digested with BglII on agarose gel electrophoresis are shown in Fig. 2 . Plasmid pNR9122 and its transconjugant plasmid had identical profiles, whereas plasmid pNR9124 and its transconjugant plasmid shared most fragments but were not completely identical.
Three transconjugants (T-122, T-142, and T-589) were tested again for donor ability by plate mating to a tetracycline-susceptible and plasmid-free C. jejuni strain, and tetracycline resistance was again transferred to the second C. jejuni recipient.
Tetracycline resistance of C. jejuni was not transferred to nalidixic acid-resistant E. coli CHS-2 by conjugation.
Restriction endonuclease digestion analysis of the plasmid DNA. Electrophoretic profiles of plasmids from C. jejuni (pNR9122, pNR9124, and pNR9142), along with those from C. coli (pNR9131, pNR9581, and pNR9589), obtained after PstI, BglII, and HindIII digestion are shown in Fig. 3 . Plasmids pNR9122, pNR9124, and pNR9142 showed identical profiles when digested with all three enzymes. Plasmids pNR9131 and pNR9581 showed identical profiles when digested with PstI (Fig. 3A, lanes 4 and 5) but showed diverse profiles with BglII and HindIII digestion, although sharing some fragments of the same size ( Fig. 3B and C, lanes 4 and  5) . On the other hand, conjugative tetracycline-, kanamycin, and chloramphenicol-resistant plasmid pNR9589 showed different profiles from those of pNR9131 and pNR9581 when digested with the three enzymes. The PstI profile of pNR9589 was identical with that of tetracycline-resistant plasmids from C. jejuni (pNR9122, pNR9124, and pNR9142), except that an extra 2.1-kb fragment was observed in pNR9589 (Fig. 3A, lanes 1 to 3 and 6) . However, the electrophoretic profiles of pNR9589, pNR9131, and pNR9581 ob- tained after digestion with the other two enzymes were different from those of the conjugative tetracycline-resistant plasmids.
Cloning of the kanamycin and chloramphenicol resistance genes. To examine the resistance genes of C. coli in more detail, we attempted to clone the genes into E. coli X1776, since it proved impossible to transfer plasmids from Campylobacter strains to E. coli by transformation or conjugation. We failed to clone the tetracycline resistance gene of C. coli to E. coli with pUC13 as a vector but were able to clone the kanamycin resistance genes of pNR9131, pNR9581, and pNR9589 to E. coli. The chloramphenicol resistance gene of pNR9589 was also cloned and expressed in E. coli. The properties of the recombinant plasmids are summarized in Table 4 . When kanamycin and chloramphenicol resistance genes were cloned frm pNR9589, the frequency of chloramphenicol-resistant transformants was 100-fold less than that of kanamycin-resistant transformants, and all the chloramphenicol-resistant transformants were also resistant to kanamycin. HindIll digestion profiles of the original and recombinant plasmids are shown in Fig. 4 . Recombinant plasmids pNR9010 and pNR9011 contained the kanamycin resistance genes of pNR9131 and pNR9581 in the 7.8-and 5. 8-kb HindIII fragments, respectively ( Table 4 ). The kanamycinresistant recombinant, pNR9012, contained the 1.4-kb HindIII fragment of pNR9589. pNR9013, which mediated kanamycin and chloramphenicol resistances, contained the 1.4-and 3.5-kb HindIII fragments. However, any one of the fragments alone did not express chloramphenicol resistance when cloned separately (data not shown), suggesting that linkage of the two Hindlll fragments is necessary for expression of chloramphenicol resistance. To see whether similarities existed among these kanamycin resistance genes, recombinant plasmids were double-digested with HindIlI and HaeIII or with HindlIl and HpaII (Fig. SA and B) . The fragments indicated by arrows in Fig. SA and B were found to be common to all recombinant plasmids. At least about 400 to 500 base pairs of the 1,400-base-pair Hindlll fragment of pNR9012 was shared by pNR9010 and pNR9011. DISCUSSION MIC test results for our clinical isolates of Campylobacter were in general agreement with those previously reported except for an unusually high incidence of tetracycline resistance in our strains (6, 11, 16, 25, 26, 28) . Tetracycline and erythromycin resistances in thermophilic campylobacters have recently been reported (3, 5, 10, 16, 26, 28) . Fifty-five percent of our C. jejuni isolates were resistant to tetracy- cline, although none of them were resistant to erythromycin. The reported incidences of tetracycline resistance are 4 to 8% (in Belgium) (25, 26) , 12% (in Canada) (11) , 30% (in the United States) (28), 38% (in Israel) (16) , and 69% (in Japan) (10) . In other Japanese reports, tetracycline resistance is also described as being common in human isolates. Vanhoof et al. showed that antimicrobial MIC distributions for C.
jejuni isolates of human origin were very comparable to those of C. jejuni isolates of animal origin (24) , and many investigators, after determining the MICs for C. jejuni and C. coli isolates from humans, poultry, and swine (5, 24, 28) , have suggested that the differences in antimicrobial susceptibility patterns might be related to the ultimate source of the strains tested. Considering this background, the fact that tetracycline resistance in poultry isolates is not as common as that in human isolates in Japan (22%) (10) might suggest the existence of another source of infection besides poultry.
The MIC patterns for the 10 C. coli isolates were considerably different from those for the C. jejuni isolates, and multiple-antibiotic resistance including tetracycline and erythromycin resistance was commonly seen. This was also noticed by Wang et al. (28) and Fliegelman et al. (6) , although the antimicrobial agents tested were not necessarily identical. It is of considerable interest that antibiotic resistance occurs far more frequently in C. coli than in C. jejuni, despite the absence of any difference in the antimicrobial agents added to animal feed.
As for the R plasmids encoding tetracycline resistance in C. jejuni, Tenover et al. have shown that they transfer tetracycline resistance and vary in size from 42 to 133 kb (22) . Our studies also demonstrate that the majority (82%) of tetracycline-resistant isolates carry plasmids from 44 to 59 jejuni strain suggests that tetracycline resistance in C. jejuni is mediated by conjugative plasmids, although other possibilities such as transformation, transduction, or chromosome mobilization have not been completely excluded. Plasmid-curing or insertion inactivation studies were not done.
Although the high incidence of multiple-antibiotic resistance in C. coli strains is well known (28) , there have been few reports concerning the plasmids involved. We isolated three plasmids from multiple-antibiotic-resistant isolates of C. coli. The restriction endonuclease digestion profiles of these plasmids were different from each other, although a few common fragments were observed (Fig. 3) , and were also different from those of the tetracycline resistance plasmid in C. jejuni. The PstI digestion profile of pNR9589 was quite similar to that of the tetracycline resistance plasmid of C. jejuni, whereas the digestion profiles with other endonucleases were different. Recently, Taylor et al. (20) and Tenover et al. (22) reported the molecular size distribution of a tetracycline resistance plasmid of Campylobacter spp. that yielded different fragments by digestion with several restriction endonucleases, although these hybridized with each other.
From cloning experiments, the kanamycin and chloramphenicol resistance genes of pNR9589 appeared to be closely linked to each other. Although kanamycin resistance was encoded in the 7.8-, 5.8-, and 1.4-kb HindIll fragments of pNR9131, pNR9581, and pNR9589, respectively (Table 4 ; Fig. 4 ), these fragments contained common smaller fragments (Fig. 5) , suggesting that the kanamycin resistance genes found in our C. coli strains were closely related. Recently, Lambert et al. isolated a strain of C. coli carrying a 47.2-kb conjugative plasmid (pIP1433) encoding both tetracycline and kanamycin resistance (13) . Its (12) . We have not yet explored these possibilities.
